(1-Adamantanecarbonyl-D-Arg0,Hyp3,beta-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin is a highly modified bradykinin analog integrating hydrophobic, aromatic, and cyclic substituents for extreme conformational refinement. These changes dramatically influence steric bulk, hydrogen-bond frameworks, and receptor engagement. The analog is ideal for probing kinin structural requirements and signaling bias. Researchers use it in deep analyses of peptide topology and binding-site mapping.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.